Primary aldosteronism ups risk of multiple autoimmune disorders
Patients with primary aldosteronism are at higher risk of incident new-onset autoimmune disease (NOAD) and all-cause mortality than individuals with essential hypertension, and such risk persists even in those treated by adrenalectomy or mineralocorticoid receptor antagonist (MRA), according to a recent study.
